Lean people with HIV can still develop fatty liver disease
Bepirovirsen leads to functional cure in one fifth of people with long-term hepatitis B
GLP-1 agonists could be a global game-changer, but need to be accessible and affordable
People with HIV fare as well as those without it after liver transplants
Hepatitis B reactivation is rare after switching from tenofovir, two European studies show
Injectable HIV treatment works for people with poor HIV control in Africa
HIV status does not affect liver transplant outcomes, 15-year Spanish study finds
Most liver disease in people with HIV in low and middle-income countries is caused by metabolic disorders
Hidden hepatitis B infection may compromise dolutegravir / lamivudine treatment
